Benjamin F. Edwards & Company’s Dentsply Sirona XRAY Stock Holding History

Benjamin F. Edwards & Company’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$116K	Hold	4,652	–	–	﹤0.01%	1071
2024 Q1	$154K	Hold	4,652	–	–	﹤0.01%	984
2023 Q4	$166K	Hold	4,652	–	–	﹤0.01%	928
2023 Q3	$159K	Hold	4,652	–	–	0.01%	791
2023 Q2	$186K	Hold	4,652	–	–	0.01%	754
2023 Q1	$183K	Hold	4,652	–	–	0.01%	747
2022 Q4	$148K	Hold	4,652	–	–	0.01%	794
2022 Q3	$132K	Hold	4,652	–	–	0.01%	796
2022 Q2	$166K	Hold	4,652	–	–	0.01%	718
2022 Q1	$229K	Hold	4,652	–	–	0.01%	645
2021 Q4	$260K	Hold	4,652	–	–	0.01%	611
2021 Q3	$270K	Hold	4,652	–	–	0.01%	580
2021 Q2	$294K	Hold	4,652	–	–	0.02%	564
2021 Q1	$297K	Hold	4,652	–	–	0.02%	576
2020 Q4	$244K	Hold	4,652	–	–	0.01%	591
2020 Q3	$203K	Sell	4,652 -688	-13%	-$30.4K	0.01%	590
2020 Q2	$235K	Sell	5,340 -2,616	-33%	-$111K	0.02%	532
2020 Q1	$309K	Sell	7,956 -773	-9%	-$39.4K	0.03%	421
2019 Q4	$494K	Hold	8,729	–	–	0.03%	389
2019 Q3	$465K	Hold	8,729	–	–	0.04%	379
2019 Q2	$509K	Hold	8,729	–	–	0.04%	352
2019 Q1	$433K	Hold	8,729	–	–	0.04%	359
2018 Q4	$325K	Hold	8,729	–	–	0.03%	380
2018 Q3	$329K	Buy	8,729 +4,030	+86%	+$168K	0.03%	412
2018 Q2	$206K	Hold	4,699	–	–	0.02%	499
2018 Q1	$236K	Hold	4,699	–	–	0.02%	460
2017 Q4	$309K	Hold	4,699	–	–	0.03%	391
2017 Q3	$281K	Hold	4,699	–	–	0.03%	378
2017 Q2	$305K	Sell	4,699 -275	-6%	-$17.4K	0.04%	350
2017 Q1	$311K	Hold	4,974	–	–	0.05%	335
2016 Q4	$287K	Buy	4,974 +125	+3%	+$7.38K	0.05%	308
2016 Q3	$288K	Buy	4,849 +150	+3%	+$9.22K	0.05%	293
2016 Q2	$292K	Hold	4,699	–	–	0.06%	275
2016 Q1	$290K	Buy	4,699 +2	+0%	+$118	0.06%	263
2015 Q4	$286K	Buy	4,697 +3	+0.1%	+$178	0.06%	263
2015 Q3	$237K	Buy	4,694 +2	+0%	+$107	0.05%	283
2015 Q2	$242K	Buy	4,692 +2	+0%	+$104	0.05%	309
2015 Q1	$239K	Buy	4,690 +2	+0%	+$103	0.05%	301
2014 Q4	$250K	Buy	4,688 +2	+0%	+$102	0.06%	275
2014 Q3	$214K	Buy	4,686 +3	+0.1%	+$141	0.05%	295
2014 Q2	$222K	Buy	4,683 +2	+0%	+$93	0.06%	283
2014 Q1	$216K	Buy	4,681 +2	+0%	+$93	0.06%	275
2013 Q4	$227K	Buy	4,679 +2	+0%	+$94	0.08%	227
2013 Q3	$203K	Buy	4,677 +3	+0.1%	+$128	0.08%	224
2013 Q2	$191K	Buy	+4,674	New	+$195K	0.08%	217

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Benjamin F. Edwards & Company's XRAY Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its Dentsply Sirona (XRAY) position steady in Q2 2024 at 4,652 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Benjamin F. Edwards & Company first reported a position in XRAY in Q2 2013 and has held it in 45 quarters since. The position peaked at $509K in Q2 2019. 381 funds tracked by Wall St. Rank hold XRAY as of Q2 2024.

Benjamin F. Edwards & Company held 4,652 shares of Dentsply Sirona worth $116K as of Q2 2024.
Benjamin F. Edwards & Company left its Dentsply Sirona share count unchanged in Q2 2024.
Dentsply Sirona made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1071 holding.
Benjamin F. Edwards & Company first reported a position in Dentsply Sirona in Q2 2013 and has held it in 45 quarters since.
Benjamin F. Edwards & Company's Dentsply Sirona position peaked at $509K in Q2 2019.
381 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.